top of page
company_01.png

DESIGN & DEVELOPMENT OF NOVEL DRUGS BASED ON A NEW TECHNOLOGY

QBR A/S

PIONEERING SOLUTIONS TO
THE GREATEST THREATS IN MODERN MEDICINE

THERE IS AN URGENT
NEED TO COMBAT VIRAL
INFECTIONS THAT CAN
CAUSE PANDEMICS.


 

THE WORLD IS HEADING
TO A POST-ANTIBIOTIC
ERA IN WHICH COMMON
INFECTIONS COULD ONCE
AGAIN KILL (WHO)

company_02.png

QBR A/S is a Danish company developing novel Anti Microbial & Anti Viral Peptides as a new class of drugs in infectious diseases.

QBR is at the forefront of the interface of Physics and Chemistry in drug design, utilizing a ground- breaking Resonant Recognition Model – RRM.

company_03.png

PARTNERSHIPS & IP

  • AMALNA Consulting (AU), RRM Technology.

  • Loma Linda University Hospital (USA), collaborative reresearch and testing facilities.

  • Ljubljana University (SLO) collaborative research and Lab level 3 testing facilities.

  • Pepscan (NL), collaboration agreement regarding development of GMP grade of Peptide Cov18A.

  • Leukocare (D), development of non-toxic solvents.

  • QBR has cooperation agreement with all parties and is the owner of the patented IP.

QBR Team

IVAN

LONCAREVIC

CEO

Physics,
Copenhagen University

More then 20 years experience as an entrepreneur and as consultant for private sector and universities, developing Innovative companies and research project in bio- physical systems.
 

PROF. IRENA
COSIC

RRM TECHNOLOGY

AMALNA Consulting
Australia


Director and founder of AMALNA consulting. Development of RRM model since 1994. Experience in biophysics, biomedical engineering and biomedical signal processing.

PROF. UROS
KRAPEZ

VIROLOGY

Ljubljana University
Slovenia

25 years research in respiratory viral infections, herpesviruses, avian pathogenics, Covid19 virus, more then 105 scientific papers published regarding viral infections.
 

PROF. HANSEL FLETCHER

RESISTANT BACTERIA

Loma Linda University Hospital, USA.

Assistant Dean;
M
icrobiology Division; Pharmaceutical Science, molecular genetics and biochemistry of microbial diseases, his research program has been focused on bacterial pathogens and recently resistant bacteria.
 

PROF. ALEN ALBRETH

BIO-CHEMISTRY

National Institute of
Chemistry, Slovenia

Specialising in  liquid chromatography
spe
ctrometry,  mass spectrometry, complex biological bio fluids,
analytical method development.
....

 

bottom of page